Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% ...
We expanded adjusted EBIT meaningfully year over year, generated strong free cash flow, and continued to gain share in our most important markets while maintaining balance sheet strength and financial ...
Level, Macro-Level Share and Cite: Fuentes, A. (2025) Postgraduate EFL Writing with GenAI across Scientific Domains: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback